Cargando…

MMAP-09 CHARACTERISTICS CORRELATING WITH SURVIVAL IN PATIENTS TREATED FOR LARGE BRAIN METASTASES

BACKGROUND: We aimed to identify factors predicting survival following treatment to large (>4cc) BrM. METHODS: From a prospective registry database, we identified 364 adult patients treated for brain metastases (BrM) or surgical cavities larger than >4 cc: 127 and 237 treated with surgery plus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gutierrez-Valencia, Enrique, Kalyvas, Aristotelis, Millar, Barbara-Ann, Laperriere, Normand, Conrad, Tatiana, Berlin, Alejandro, Weiss, Jessica, Zadeh, Gelareh, Bernstein, Mark, Kongkham, Paul, Shultz, David B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354160/ http://dx.doi.org/10.1093/noajnl/vdac078.065

Ejemplares similares

MLTI-06. Surgical resection plus stereotactic radiosurgery versus SRS alone for large brain metastases: a comparative study
por: Gutierrez, Enrique, et al.
Publicado: (2021)

CLRM-20 IDENTIFYING RISK FACTORS AND ANALYZING SURVIVAL FOLLOWING PACHYMENINGEAL FAILURE
por: Kalyvas, Aristotelis, et al.
Publicado: (2022)

SURG-13. Multiplicity does not affect outcomes in patients with surgically treated brain metastases
por: Yang, Kaiyun, et al.
Publicado: (2021)

Multiplicity does not significantly affect outcomes in brain metastasis patients treated with surgery
por: Yang, Kaiyun, et al.
Publicado: (2022)

Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases
por: Ramotar, Matthew, et al.
Publicado: (2019)

MMAP-10 ADVERSE RADIATION EFFECT AFTER STEREOTACTIC RADIOSURGERY AND IMMUNOTHERAPY/TARGETED THERAPY FOR MELANOMA BRAIN METASTASES
por: Phuong, Christina, et al.
Publicado: (2022)

Clinicopathologic and Treatment Features of Long-Term Surviving Brain Metastasis Patients
por: Dasgupta, Archya, et al.
Publicado: (2021)

MMAP-11 VOLUMETRIC STUDY OF BRAIN METASTASES IN EGFR-POSITIVE NSCLC TREATED WITH OSIMERTINIB WITH OR WITHOUT CNS-DIRECTED RADIATION THERAPY
por: Ni, Lisa, et al.
Publicado: (2022)

Radiosurgery for brainstem metastases with and without whole brain radiotherapy: clinical series and literature review
por: Murray, Louise, et al.
Publicado: (2016)

MMAP-07 IMPACT OF SINGLE AND DUAL IMMUNE CHECKPOINT BLOCKADE ON RISK OF RADIATION NECROSIS AMONG PATIENTS WITH BRAIN METASTASES TREATED WITH STEREOTACTIC RADIOSURGERY
por: Vaios, Eugene, et al.
Publicado: (2022)

MMAP-04 CYTOTOXIC, TUMOR-HOMING INDUCED NEURAL STEM CELLS AS AN ADJUVANT TO RADIATION IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER LEPTOMENINGEAL METASTASES
por: Mercer-Smith, Alison, et al.
Publicado: (2022)

Special issue: advances in the multimodality management of brain metastases and ongoing approaches to further improve their treatment
por: Zuccato, Jeffrey A, et al.
Publicado: (2021)

MMAP-05 PHASE I STUDY OF CONCURRENT PAXALISIB AND RADIATION THERAPY IN PATIENTS WITH SOLID TUMOR BRAIN METASTASES OR LEPTOMENINGEAL METASTASES HARBORING PI3K PATHWAY MUTATIONS: RESULTS FROM THE DOSE-ESCALATION COHORT
por: Yang, Jonathan, et al.
Publicado: (2022)

Short Course Hypofractionated Radiotherapy for Frail or Elderly Patients With Meningioma
por: Sarhan, Nasim, et al.
Publicado: (2020)

MMAP-06 INTEGRATED TEAM-BASED BRAIN METASTASIS CARE REDUCES PATIENT VISITS AND SHORTENS TIME TO ADJUVANT IRRADIATION
por: Moss, Nelson S, et al.
Publicado: (2022)

The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery
por: Hainc, Nicolin, et al.
Publicado: (2021)

MMAP-02 A POPULATION - BASED STUDY ON RADIATION THERAPY FOR BRAIN METASTASIS FROM MALIGNANT MELANOMA IN BRITISH COLUMBIA: EVALUATING THE IMPACT OF IMMUNOTHERAPY AND STEREOTACTIC TECHNIQUES
por: Bahl, Gaurav, et al.
Publicado: (2022)

71. MGMT PROMOTER METHYLATION IS A PROGNOSTIC BIOMARKER IN EGFR MUTANT LUNG ADENOCARCINOMA WITH BRAIN METASTASES
por: Mamatjan, Yasin, et al.
Publicado: (2020)

LITTing up Gliomas—Is the Future Bright?
por: O’Halloran, Philip J., et al.
Publicado: (2022)

RADI-09. Clinical factors associated with death after radiotherapy for brain metastases
por: Natesan, Divya, et al.
Publicado: (2021)

Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases
por: LWU, SHELLY, et al.
Publicado: (2013)

BSCI-02 CSF PROTEOMICS AS A MINIMALLY-INVASIVE STRATEGY FOR DISTINGUISHING BRAIN METASTASES FROM OTHER PRIMARY BRAIN MALIGNANCIES
por: Mansouri, Alireza, et al.
Publicado: (2022)

MMAP-08 CHEMO-REIRRADIATION (NORMOFRACTIONATED VS. HYPOFRACTIONATED) WITH OR WITHOUT BEVACIZUMAB IN RECURRENT ADULT DIFFUSE HIGH-GRADE GLIOMA (COBRA): PHASE III RANDOMIZED CONTROLLED TRIAL WITH A 2 X 2 FACTORIAL DESIGN
por: Baviskar, Yamini, et al.
Publicado: (2022)

NGMA-1. Quantification of IDH mutant alleles predicts outcome in diffuse gliomas
por: Voisin, Mathew, et al.
Publicado: (2021)

Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center survey
por: Khan, Osaama H., et al.
Publicado: (2015)

Artificial Intelligence, Radiomics, and Deep Learning in Neuro-Oncology
por: Galldiks, Norbert, et al.
Publicado: (2021)

BSCI-09. Multiomic single cell analysis reveals emerging principles of tumor immune microenvironment inherent to NSCLC brain metastases
por: Wen, Lei, et al.
Publicado: (2021)

Special issue: a contemporary landscape of the clinical and biological research in neurofibromatosis type 1
por: Suppiah, Suganth, et al.
Publicado: (2020)

ECOA-8. Lung adenocarcinoma brain metastasis prediction using tumor DNA methylation profiling
por: Zuccato, Jeffrey, et al.
Publicado: (2021)

Introduction: Ongoing clinical challenges in the management of meningiomas and future directions
por: Wang, Justin Z, et al.
Publicado: (2023)

SYST-09 IMPACT OF END-STAGE RENAL DISEASE AND CONCOMITANT DIALYSIS ON THE EFFICACY OF IMMUNOTHERAPY IN BRAIN METASTASES PATIENTS: A PROPENSITY-MATCHED SURVIVAL ANALYSIS
por: Baroz, Angel, et al.
Publicado: (2022)

DDRE-09. THERAPEUTIC TARGETING OF PURINE METABOLISM IN DIPG
por: Mersich, Ian, et al.
Publicado: (2021)

OTHR-09. IDENTIFYING EPIGENETIC SIGNATURES IN LUNG ADENOCARCINOMAS THAT PREDICT DEVELOPMENT OF BRAIN METASTASIS
por: Zuccato, Jeffrey, et al.
Publicado: (2019)

MMAP: a cloud computing platform for mining the maximum accuracy of predicting phenotypes from genotypes
por: Huang, Wei, et al.
Publicado: (2020)

Quality of life in patients with neurofibromatosis type 1 and 2 in Canada
por: Hamoy-Jimenez, Geohana, et al.
Publicado: (2020)

CBMS-09 Intercellular communication at glioblastoma stem cell niches
por: Hide, Takuichiro, et al.
Publicado: (2020)

SPCR-04 EFFECTS OF BRAIN METASTASES ON NEUROCOGNITIVE FUNCTION: BASELINE RESULTS OF A LONGITUDINAL TRIAL
por: Higazy, Randa, et al.
Publicado: (2022)

Unusual Orange-Colored Choroidal Metastases
por: Krema, Hatem, et al.
Publicado: (2013)

BT-09 Anhidrosis in neurohypophyseal germinoma treated with CBDCA and VP-16
por: Adachi, Koji, et al.
Publicado: (2020)

CS-09 Extra-parenchymal (Peripheral) Atypical Teratoid / Rhabdoid Tumors
por: Oka, Hidehiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iuabmkck9idre4hsk3mcjfc2ve